CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA

Molecular Cancer

Volumn 14, Issue 1, 2015, Pages

  Conigliaro, Alice ^a   Costa, Viviana ^b   Lo Dico, Alessia ^c   Saieva, Laura ^c   Buccheri, Simona ^c,d   Dieli, Francesco ^c   Manno, Mauro ^e   Raccosta, Samuele ^e   Mancone, Carmine ^a,f   Tripodi, Marco ^f,g   De Leo, Giacomo ^c   Alessandro, Riccardo ^c,h  

^a POLICLINICO UMBERTO I   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

^e CNR   (Italy)

^f NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

Angiogenesis; CD90+ liver cancer cells; Exosomes; Long non coding RNA H19

Indexed keywords

LONG UNTRANSLATED RNA; RNA H19; THY 1 ANTIGEN; H19 LONG NON-CODING RNA;

ANGIOGENESIS; ARTICLE; CANCER STEM CELL; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXOSOME; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE SEQUENCE; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LIVER CANCER; MOLECULARLY TARGETED THERAPY; PHENOTYPE; PLASMID; TUMOR MICROENVIRONMENT; UMBILICAL VEIN ENDOTHELIAL CELL; GENETICS; LIVER TUMOR; METABOLISM; TUMOR CELL LINE;

ANTIGENS, THY-1; CELL ADHESION; CELL LINE, TUMOR; ENDOTHELIAL CELLS; EXOSOMES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIVER NEOPLASMS; PHENOTYPE; RNA, LONG NONCODING;

EID: 84939157617     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/s12943-015-0426-x     Document Type: Article

References (52)

1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245-55. doi: 10.1016/S0140-6736(11)61347-0S0140-6736(11)61347-0 .
2. Uchino K, Tateishi R, Shiina S, Kanda M, Masuzaki R, Kondo Y, et al. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer. 2011;117(19):4475-83. doi: 10.1002/cncr.25960 .
3. Yoo DJ, Kim KM, Jin YJ, Shim JH, Ko GY, Yoon HK, et al. Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients? J Gastroenterol Hepatol. 2011;26(1):145-54. doi: 10.1111/j.1440-1746.2010.06341.x .
4. Roncalli M, Park YN, Di Tommaso L. Histopathological classification of hepatocellular carcinoma. Digestive and liver disease. Off J Italian Soc Gastroenterol Italian Assoc Study Liver. 2010;42 Suppl 3:S228-34. doi: 10.1016/S1590-8658(10)60510-5 .
5. Suzuki A, Zheng Y, Kondo R, Kusakabe M, Takada Y, Fukao K, et al. Flow-cytometric separation and enrichment of hepatic progenitor cells in the developing mouse liver. Hepatology. 2000;32(6):1230-9. doi: 10.1053/jhep.2000.20349 .
6. Oishi N, Yamashita T, Kaneko S. Molecular biology of liver cancer stem cells. Liver Cancer. 2014;3(2):71-84. doi: 10.1159/000343863 .
7. Yoon SK. The biology of cancer stem cells and its clinical implication in hepatocellular carcinoma. Gut Liver. 2012;6(1):29-40. doi: 10.5009/gnl.2012.6.1.29 .
8. Yao Z, Mishra L. Cancer stem cells and hepatocellular carcinoma. Cancer Biol Therapy. 2009;8(18):1691-8.
9. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology. 2006;44(1):240-51. doi: 10.1002/hep.21227 .
10. Ma S, Tang KH, Chan YP, Lee TK, Kwan PS, Castilho A, et al. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell. 2010;7(6):694-707. doi: 10.1016/j.stem.2010.11.010 .
11. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell. 2008;13(2):153-66. doi: 10.1016/j.ccr.2008.01.013 .
12. Yamashita T, Honda M, Nakamoto Y, Baba M, Nio K, Hara Y, et al. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma. Hepatology. 2013;57(4):1484-97. doi: 10.1002/hep.26168 .
13. Rege TA, Hagood JS. Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses. Biochim Biophys Acta. 2006;1763(10):991-9. doi: 10.1016/j.bbamcr.2006.08.008 .
14. Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, Deregibus MC, et al. Isolation and characterization of a stem cell population from adult human liver. Stem Cells. 2006;24(12):2840-50. doi: 10.1634/stemcells.2006-0114 .
15. Sukowati CH, Anfuso B, Torre G, Francalanci P, Croce LS, Tiribelli C. The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study. PLoS One. 2013;8(10):e76830. doi: 10.1371/journal.pone.0076830 .
16. Lingala S, Cui YY, Chen X, Ruebner BH, Qian XF, Zern MA, et al. Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Exp Mol Pathol. 2010;89(1):27-35. doi: 10.1016/j.yexmp.2010.05.005 .
17. Yu XH, Xu LB, Liu C, Zhang R, Wang J. Clinicopathological characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi. Dig Dis Sci. 2011;56(1):252-9. doi: 10.1007/s10620-010-1256-8 .
18. Lu JW, Chang JG, Yeh KT, Chen RM, Tsai JJ, Hu RM. Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis. Acta Histochem. 2011;113(8):833-8. doi: 10.1016/j.acthis.2011.01.001 .
19. Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, Lau CK, et al. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology. 2008;47(3):919-28. doi: 10.1002/hep.22082 .
20. Guo Z, Li LQ, Jiang JH, Ou C, Zeng LX, Xiang BD. Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma. World J Gastroenterol. 2014;20(8):2098-106. doi: 10.3748/wjg.v20.i8.2098 .
21. Fang L, Zhang HB, Li H, Fu Y, Yang GS. miR-548c-5p inhibits proliferation and migration and promotes apoptosis in CD90(+) HepG2 cells. Radiol Oncol. 2012;46(3):233-41. doi: 10.2478/v10019-012-0025-z .
22. Fontana S, Saieva L, Taverna S, Alessandro R. Contribution of proteomics to understanding the role of tumor-derived exosomes in cancer progression: state of the art and new perspectives. Proteomics. 2013;13(10-11):1581-94. doi: 10.1002/pmic.201200398 .
23. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current protocols in cell biology / editorial board, Juan S Bonifacino [et al]. 2006;Chapter 3:Unit 3 22. doi: 10.1002/0471143030.cb0322s30.
24. Braicu C, Tomuleasa C, Monroig P, Cucuianu A, Berindan-Neagoe I, Calin GA. Exosomes as divine messengers: are they the Hermes of modern molecular oncology? Cell Death Differ. 2015;22(1):34-45. doi: 10.1038/cdd.2014.130 .
25. Kogure T, Yan IK, Lin WL, Patel T. Extracellular vesicle-mediated transfer of a novel long noncoding RNA TUC339: a mechanism of intercellular signaling in human hepatocellular cancer. Genes Cancer. 2013;4(7-8):261-72. doi: 10.1177/1947601913499020 .
26. Taverna S, Flugy A, Saieva L, Kohn EC, Santoro A, Meraviglia S, et al. Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis. Int J Cancer. 2012;130(9):2033-43. doi: 10.1002/ijc.26217 .
27. Corrado C, Raimondo S, Saieva L, Flugy AM, De Leo G, Alessandro R. Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells. Cancer Lett. 2014;348(1-2):71-6. doi: 10.1016/j.canlet.2014.03.009 .
28. Webber J, Yeung V, Clayton A. Extracellular vesicles as modulators of the cancer microenvironment. Semin Cell Dev Biol. 2015;40:27-34. doi: 10.1016/j.semcdb.2015.01.013 .
29. Eun JR, Jung YJ, Zhang Y, Zhang Y, Tschudy-Seney B, Ramsamooj R, et al. Hepatoma SK Hep-1 cells exhibit characteristics of oncogenic mesenchymal stem cells with highly metastatic capacity. PLoS One. 2014;9(10):e110744. doi: 10.1371/journal.pone.0110744 .
30. Yu FJ, Zheng JJ, Dong PH, Fan XM. Long non-coding RNAs and hepatocellular carcinoma. Mol Clin Oncol. 2015;3(1):13-7. doi: 10.3892/mco.2014.429 .
31. Sun J, Bie B, Zhang S, Yang J, Li Z. Long Non-coding RNAs: critical players in hepatocellular carcinoma. Int J Mol Sci. 2014;15(11):20434-48. doi: 10.3390/ijms151120434 .
32. Pan YF, Qin T, Feng L, Yu ZJ. Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma. J Huazhong Univ Sci Technol Med sci Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban. 2013;33(1):96-101. doi: 10.1007/s11596-013-1078-y .
33. Yang X, Xie X, Xiao YF, Xie R, Hu CJ, Tang B et al. The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinoma. Cancer letters. 2015. doi: 10.1016/j.canlet.2015.02.035
34. George J, Patel T. Noncoding RNA as therapeutic targets for hepatocellular carcinoma. Semin Liver Dis. 2015;35(1):63-74. doi: 10.1055/s-0034-1397350 .
35. Ma C, Nong K, Zhu H, Wang W, Huang X, Yuan Z, et al. H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. Tumour biology. J Int Soc Oncodev Biol Med. 2014;35(9):9163-9. doi: 10.1007/s13277-014-2185-5 .
36. Matouk IJ, Raveh E, Abu-lail R, Mezan S, Gilon M, Gershtain E, et al. Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys Acta. 2014;1843(7):1414-26. doi: 10.1016/j.bbamcr.2014.03.023 .
37. Takahashi K, Yan IK, Kogure T, Haga H, Patel T. Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS open Bio. 2014;4:458-67. doi: 10.1016/j.fob.2014.04.007 .
38. Ye J, Wu D, Wu P, Chen Z, Huang J. The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment. Tumour biology. J Int Soc Oncodev Biol Med. 2014;35(5):3945-51. doi: 10.1007/s13277-013-1561-x .
39. Kahlert C, Kalluri R. Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl). 2013;91(4):431-7. doi: 10.1007/s00109-013-1020-6 .
40. Takahashi K, Yan IK, Haga H, Patel T. Modulation of hypoxia-signaling pathways by extracellular linc-RoR. J Cell Sci. 2014;127(Pt 7):1585-94. doi: 10.1242/jcs.141069 .
41. Moran VA, Perera RJ, Khalil AM. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 2012;40(14):6391-400. doi: 10.1093/nar/gks296 .
42. Zhang Y, Tycko B. Monoallelic expression of the human H19 gene. Nat Genet. 1992;1(1):40-4. doi: 10.1038/ng0492-40 .
43. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature. 2000;405(6785):486-9. doi: 10.1038/35013106 .
44. Dey BK, Pfeifer K, Dutta A. The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration. Genes Dev. 2014;28(5):491-501. doi: 10.1101/gad.234419.113 .
45. Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, Yan L, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013;52(1):101-12. doi: 10.1016/j.molcel.2013.08.027 .
46. Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J, et al. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J. 2012;279(17):3159-65. doi: 10.1111/j.1742-4658.2012.08694.x .
47. Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett. 2013;333(2):213-21. doi: 10.1016/j.canlet.2013.01.033 .
48. Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, et al. The H19 non-coding RNA is essential for human tumor growth. PLoS One. 2007;2(9):e845. doi: 10.1371/journal.pone.0000845 .
49. Fellig Y, Ariel I, Ohana P, Schachter P, Sinelnikov I, Birman T, et al. H19 expression in hepatic metastases from a range of human carcinomas. J Clin Pathol. 2005;58(10):1064-8. doi: 10.1136/jcp.2004.023648 .
50. Kim DK, Zhang L, Dzau VJ, Pratt RE. H19, a developmentally regulated gene, is reexpressed in rat vascular smooth muscle cells after injury. J Clin Invest. 1994;93(1):355-60. doi: 10.1172/JCI116967 .
51. Han DK, Khaing ZZ, Pollock RA, Haudenschild CC, Liau G. H19, a marker of developmental transition, is reexpressed in human atherosclerotic plaques and is regulated by the insulin family of growth factors in cultured rabbit smooth muscle cells. J Clin Invest. 1996;97(5):1276-85. doi: 10.1172/JCI118543 .
52. Noto R, Santangelo MG, Ricagno S, Mangione MR, Levantino M, Pezzullo M, et al. The tempered polymerization of human neuroserpin. PLoS One. 2012;7(3):e32444. doi: 10.1371/journal.pone.0032444 .